GENIALIS

genialis-logo

Genialis is a precision medicine data science company focused on new ways to treat disease. Blending computational biology and AI-based methods, Genialis merges and models data at the intersection of clinical and translational medicine and drug discovery. Genialis is trusted by biopharma and big pharma alike, to validate targets, predict biomarkers and optimally position novel drugs. Together, Genialis and its partners are bringing improved solutions to drug discovery to change people's lives.

#SimilarOrganizations #People #Financial #Website #More

GENIALIS

Social Links:

Industry:
Artificial Intelligence Bioinformatics Biotechnology Data Integration Data Mining Data Visualization Health Care Life Science

Founded:
2011-01-01

Address:
Houston, Texas, United States

Country:
United States

Website Url:
http://www.genialis.com

Total Employee:
11+

Status:
Active

Contact:
(832) 356-4612

Email Addresses:
[email protected]

Total Funding:
2.49 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Font Awesome


Similar Organizations

menten-ai-logo

Menten AI

Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.

fabric-genomics-formerly-omicia-logo

Fabric Genomics (formerly Omicia)

Global healthcare platform for genomics-driven precision medicine. Fabric' proven AI algorithms power genomic insights.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.


Current Advisors List

drew-volpe_image

Drew Volpe Board Member @ Genialis
Board_member
2017-10-01

elia-stupka_image

Elia Stupka Board Member @ Genialis
Board_member
2015-09-01

blaz-zupan_image

Blaz Zupan Scientific Advisor @ Genialis
Advisor
2013-02-26

Current Employees Featured

klemen-hrovat_image

Klemen Hrovat
Klemen Hrovat Co-founder and Commercial Operations @ Genialis
Co-founder and Commercial Operations
2013-02-26

miha-stajdohar_image

Miha Stajdohar
Miha Stajdohar CTO @ Genialis
CTO
2013-02-26

tjasa-krisper-kutin_image

Tjasa Krisper-Kutin
Tjasa Krisper-Kutin Chief Operating Officer @ Genialis
Chief Operating Officer
2018-02-01

rafael-rosengarten_image

Rafael Rosengarten
Rafael Rosengarten CPO @ Genialis
CPO
2015-10-01

rafael-rosengarten_image

Rafael Rosengarten
Rafael Rosengarten CEO @ Genialis
CEO
2018-07-11

luka-ausec_image

Luka Ausec
Luka Ausec Chief Discovery Officer @ Genialis
Chief Discovery Officer
2019-10-01

Founder


klemen-hrovat_image

Klemen Hrovat

luka-ausec_image

Luka Ausec

miha-stajdohar_image

Miha Stajdohar

nejc-skoberne_image

Nejc Skoberne

rafael-rosengarten_image

Rafael Rosengarten

Investors List

dilek-dayinlarli_image

Dilek Dayinlarli

Dilek Dayinlarli investment in Seed Round - Genialis

redalpine-venture-partners_image

Redalpine

Redalpine investment in Seed Round - Genialis

procyon-ventures_image

First Star Ventures

First Star Ventures investment in Seed Round - Genialis

easme_image

EASME - EU Executive Agency for SMEs

EASME - EU Executive Agency for SMEs investment in Grant - Genialis

Official Site Inspections

http://www.genialis.com

Unable to get host informations!!!

Loading ...

More informations about "Genialis"

Genialis, the RNA biomarker company

Genialis uses machine-learning to discover RNA biomarkers and position oncology drugs to advance translational research and cancer drug development. Reimagining biomarkers with RNA + AI: Precision Oncology for Every Patient โ€ฆSee details»

Genialis - LinkedIn

Genialis develops and validates clinically actionable biomarkers informed by the worldโ€™s most ethnographically diverse cancer data sets to better predict patient responses and guide โ€ฆSee details»

Meet Our Team - Genialis

Genialis is the RNA biomarker company We are creating a world where healthcare delivers the best possible outcomes for patients, their families and communities. Genialis develops and โ€ฆSee details»

Genialis Company Profile 2024: Valuation, Funding & Investors

Genialis is headquartered in MA. What is the size of Genialis? Genialis has 42 total employees. What industry is Genialis in? Genialisโ€™s primary industry is Drug Discovery. Is Genialis a โ€ฆSee details»

Compliance - Genialis

Genialis stands for excellence in compliance, setting the benchmark for data security and regulatory conformity in biotech. Committed to Ethics, Transparency, and Integrity At Genialis, โ€ฆSee details»

Genialis - CRO Database - ICH GCP

Genialis is a data science and drug discovery company focused on new ways to treat disease. Blending computational biology and AI-based methods, Genialis merges and models data at โ€ฆSee details»

Genialis Company Profile - Office Locations, Competitors ... - Craft

Genialis has 5 employees at their 1 location and $2.43 m in total funding,. See insights on Genialis including office locations, competitors, revenue, financials, executives, subsidiaries โ€ฆSee details»

Genialis - Funding, Financials, Valuation & Investors - Crunchbase

Genialis is funded by 8 investors. redalpine and P5 Health Ventures are the most recent investors. Genialis has a post-money valuation in the range of $10M to $50M as of Mar 29, 2023, โ€ฆSee details»

Genialis - Contacts, Employees, Board Members, Advisors & Alumni

Organization. Genialis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Genialis has 5 board members and โ€ฆSee details»

Genialis, Inc. - Scientist.com

Genialis is a computational precision medicine company focused on oncology. We are the RNA biomarker company. We build algorithms for precision medicine in cancer. Get started If your โ€ฆSee details»

Genialis Raises $13M to Build Clinical Biomarkers ... - Markets Insider

Mar 29, 2023 Genialis is attending AACR 2023 from April 14-19, 2023, in Orlando, Fla., where it is co-presenting a poster with OncXerna Therapeutics and Regeneron Pharmaceuticals.See details»

Targeted Cancer Treatments with Rafael Rosengarten from Genialis

Sep 4, 2023 Rafael predicts the future impact of Genialis and shares his goals for the company. Quotes: โ€œ[Genialis applies] machine learning to try to help patients find the best drugs for their โ€ฆSee details»

Genialis a Winner in Inc.โ€™s 2023 Best in Business Awards in AI & Data

Dec 6, 2023 Genialis has been named as a winner in Inc.'s 2023 Best in Business list in the AI and Data category, a prestigious award honoring the businesses that have made the greatest โ€ฆSee details»

Genialis Raises $13M to Build Clinical Biomarkers that Predict โ€ฆ

Mar 29, 2023 Genialis is attending AACR 2023 from April 14-19, 2023, in Orlando, Fla., where it is co-presenting a poster with OncXerna Therapeutics and Regeneron Pharmaceuticals.See details»

Genialis Harnesses RNA-seq Platform to Advance Precision โ€ฆ

Nov 9, 2020 Genialis remained an active member of the Alliance for Artificial Intelligence in Healthcare, most recently contributing to the organizationโ€™s webinar series on the various โ€ฆSee details»

Genialis Raises $13M to Build Clinical Biomarkers that Predict โ€ฆ

Mar 29, 2023 Genialis also co-authored a paper in the Journal of Clinical Oncology describing OncXerna's navicixizumab ph1b trial, including retrospective analysis with the Xerna TME โ€ฆSee details»

Rafael Rosengarten of Genialis On 5 Things We Must Do To

Oct 15, 2024 Genialis has recently begun discussions with a potential collaborator in India that is doing an ambitious job of bringing precision medicine tools, which have become rather โ€ฆSee details»

Genialis Releases Improved Version of Expressions for Faster, More ...

Apr 20, 2022 Genialis is trusted by biopharma and big pharma alike, and together, we bring precision to medicine. Contacts. Andrea Vuturo [email protected] +1-415-689-8414 โ€ฆSee details»

Talking Precision Medicine podcast E30: Genialis leadership

May 31, 2023 TPM E30 with the Genialis leadership team explores building an impactful company culture that puts people first in healthcare innovation. Welcome to Talking Precision โ€ฆSee details»

linkstock.net © 2022. All rights reserved